150556-72-2

Usage

General Description

The chemical 2,4-Thiazolidinedione, 5-[(4-hydroxyphenyl)methyl]-3-(triphenylmethyl)- is a compound with potential pharmaceutical properties. It belongs to the class of thiazolidinediones, which are known for their antidiabetic and anti-inflammatory effects. This particular compound contains a thiazolidinedione ring, a hydroxyphenyl group, and a triphenylmethyl group. These structural features may contribute to its biological activities, such as insulin sensitizing and anti-inflammatory properties, making it a potential candidate for drug development in the treatment of diabetes and inflammatory diseases. Further research is needed to fully understand and harness the therapeutic potential of 2,4-Thiazolidinedione, 5-[(4-hydroxyphenyl)methyl]-3-(triphenylmethyl)-.

Downstream Products

• 178055-16-8 5-[4-(2-phthalimidooxyethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 
• 223132-71-6 5-{4-[5-(4-acetoxy-2,3,5-trimethylphenoxy)-3-methyl-3H-imidazo[4,5-b]pyridin-2-ylmethoxy]benzyl}-3-triphenylmethylthiazolidine-2,4-dione 
• 223133-07-1 5-[4-(6-pentafluorophenoxy-1-methyl-1H-benzimidazole-2-ylmethoxy)benzyl]-3-triphenylmethylthiazolidine-2,4-dione 
• 175717-66-5 5-[4-{2(R)-[5(S)-(3-chlorophenoxymethyl)-2-oxooxazolidin-3-yl]propoxy}benzyl]-3-triphenylmethylthiazolidine-2,4-dione 
• 175718-01-1 5-{4-[2-(5-3'-Fluorophenoxymethyl-2-oxooxazolidin-3-yl)propoxy]benzyl}-3-triphenylmethylthiazolidin-2,4-dione 
• 175718-30-6 5-{4-[4-(5-3'-chlorophenoxymethyl-2-oxooxazolidin-3-yl)butoxy]benzyl}-3-triphenylmethylthiazolidine-2,4-dione 
• 175718-34-0 5-{4-[2-(2-3'-chlorophenoxymethylmorpholino)propoxy]benzyl}-3-triphenylmethylthiazolidine-2,4-dione 
• 957763-81-4 5-[4-(1-ethyl-1,2,3,4-tetrahydroquinolin-2-ylmethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 
• 957763-82-5 5-[4-(1-propyl-1,2,3,4-tetrahydroquinolin-2-ylmethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 
• 957763-83-6 5-[4-(1-isopropyl-1,2,3,4-tetrahydroquinolin-2-ylmethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 
• 957763-84-7 5-[4-(1-butyl-1,2,3,4-tetrahydroquinolin-2-ylmethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 
• 957763-85-8 5-[4-(1-pentyl-1,2,3,4-tetrahydroquinolin-2-ylmethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 
• 957763-86-9 5-[4-(1-isopentyl-1,2,3,4-tetrahydroquinolin-2-ylmethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 
• 957763-87-0 5-[4-(1-heptyl-1,2,3,4-tetrahydroquinolin-2-ylmethoxy)benzyl]-3-tritylthiazolidine-2,4-dione 

Relevant academic research and scientific papers

Thiazolidine compounds containing a quinone group, their preparation and their therapeutic uses

Compounds of formula (I): STR1 (wherein: R1 is alkyl; R2 and R3 are each alkyl or alkoxy, or R2 and R3 together form an optionally substituted benzene ring and, when R2 and R3 together form said benzene ring, R1 is hydrogen, halogen or alkyl; R4 and R5 both represent hydrogen, or together represent a single carbon-carbon bond; W is a single bond or alkylene; and Z is a hydrogen atom or a cation) have valuable therapeutic and prophylactic activities, including anti-diabetic activities.

Thiazolidine compounds, their preparation and their therapeutic uses

Compounds of formula (I): (in which: R1 is alkyl; R2 and R3 are each alkyl or alkoxy, or R2 and R3 together form an optionally substituted benzene ring, and, when R2 and R3 together form said benzene ring, R1 is hydrogen, halogen or alkyl; R4 and R5 are hydrogen, or R4 and R5 together represent a single carbon-carbon bond; Y1 and Y2 are each hydrogen, alkyl, acyl, or optionally substituted benzoyl, naphthoyl, pyridine-carbonyl or quinolinecarbonyl; W is a single bond or alkylene; and Z is hydrogen or a cation) have valuable therapeutic and prophylactic activities, including anti-diabetic activities.